Clinical trials
Completed Kidney Neoplasms trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2017 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 3 |
| Fuda Cancer Hospital, Guangzhou | 2 |
| Peking University First Hospital | 2 |
| Bristol-Myers Squibb | 1 |
| Cancer Foundation, China | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kidney Neoplasms | 9 |
| Carcinoma, Renal Cell | 3 |
| Kidney Diseases | 1 |
| Neoplasms, Second Primary | 1 |
| Neoplastic Cells, Circulating | 1 |
| Recurrence | 1 |
| Urogenital Neoplasms | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.